Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making
Oncology Nursing Forum · 2024
DOI: 10.1188/24.onf.199-208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Nursing Forum, 2024. Verfasst von Evelyn Robles-Rodriguez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Outreach Programs, Cooper University Hospital, Camden, NJ. Hauptthemen laut MEDLINE: Breast Neoplasms, Precision Medicine, Genetic Testing, Decision Making.
Abstract (Originalsprache)
PURPOSE: To understand awareness of genetic and genomic testing, as well as decision-making, in women diagnosed with breast cancer. PARTICIPANTS & SETTING: 29 African American/Black and Latina/Hispanic women diagnosed with breast cancer. METHODOLOGIC APPROACH: A semistructured interview guide was used in focus groups conducted via videoconference. Transcripts were analyzed using thematic analysis. FINDINGS: Many of the women understood the concept of genetic testing to identify the BRCA1/BRCA2 variant, but none of them were aware of genomic testing and its implications for personalized medicine. Participants discussed provider and patient roles in treatment decision-making, identifying roles that the physician might play in treatment planning, from primary decision-maker to collaborator. IMPLICATIONS FOR NURSING: As the number of precision cancer treatments expands, patients must be able to comprehend the information provided to make informed decisions about their treatment. Providers should do a better job of explaining potential treatments so that patients feel they are part of the decision-making process. Addressing gaps in treatment access and uptake requires providers to prioritize patient engagement and understanding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Outreach Programs, Cooper University Hospital, Camden, NJ.
- Salisbury University.
- Widener University.
- Living Beyond Breast Cancer.
- MD Anderson Cancer Center at Cooper.
- Rutgers University.
Zitieren
APA
Robles-Rodriguez, E., Houser, L., Sanchez, B., Ormerod, C., Washburn, S., Oertle, S. K., & Jerome-D'Emilia, B. (2024). Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making. Oncology Nursing Forum. https://doi.org/10.1188/24.onf.199-208
Vancouver
Robles-Rodriguez E, Houser L, Sanchez B, Ormerod C, Washburn S, Oertle SK, et al. Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making. Oncology Nursing Forum. 2024. doi:10.1188/24.onf.199-208
BibTeX
@article{RoblesRodriguez2024,
author = {Robles-Rodriguez, Evelyn and Houser, Linda and Sanchez, Belkys and Ormerod, Catherine and Washburn, Stefanie and Oertle, Staci K and Jerome-D'Emilia, Bonnie},
title = {Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making},
journal = {Oncology Nursing Forum},
year = {2024},
doi = {10.1188/24.onf.199-208}
}
EUVIMED